Danaher's Q1 Revenues up 31 Percent, Aided by Beckman Coulter Purchase
April 19, 2012
Danaher's Q1 Revenues up 31 Percent, Aided by Beckman Coulter Purchase
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Sharp Increase in Life Sciences, Diagnostics Drive Danaher Q2 Revenues up 25 Percent
July 19, 2012 / GenomeWeb Daily News - Danaher Q3 Revenues Increase 46 Percent
October 20, 2011 / GenomeWeb Daily News - Automation, Increased Throughput Key to Moving Mass Spec-Based Proteomics into the Clinic
February 11, 2011 / ProteoMonitor - UPDATE: Danaher's Life Science and Dx Sales Inch up 1 Percent in Q1
April 18, 2013 / GenomeWeb Daily News - NUI-Galway Group Ramps up Commercial MDx Efforts via Spinout Firm, Company Partnerships
February 21, 2013 / PCR Insider